Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors

Outcomes of nonmyeloablative (NMA) haploidentical (haplo) blood or marrow transplant (BMT) with post transplantation cyclophosphamide (PTCy) using non-first-degree relatives are unknown. We evaluated 33 consecutive adult patients (median age, 56 years) with hematologic malignancies who underwent NMA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Elmariah, Hany, Kasamon, Yvette L., Zahurak, Marianna, Macfarlane, Karen W., Tucker, Noah, Rosner, Gary L., Bolaños-Meade, Javier, Fuchs, Ephraim J., Wagner-Johnston, Nina, Swinnen, Lode J., Huff, Carol Ann, Matsui, William H., Gladstone, Douglas E., McCurdy, Shannon R., Borrello, Ivan, Gocke, Christian B., Shanbhag, Satish, Cooke, Kenneth R., Ali, Syed Abbas, Brodsky, Robert A., DeZern, Amy E., Luznik, Leo, Jones, Richard J., Ambinder, Richard F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439277/
https://ncbi.nlm.nih.gov/pubmed/29452245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.02.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados